0.7499
Orgenesis Inc stock is traded at $0.7499, with a volume of 120.
It is down -36.98% in the last 24 hours and down -36.98% over the past month.
See More
Previous Close:
$1.19
Open:
$0.7499
24h Volume:
120
Relative Volume:
1.60
Market Cap:
$N/A
Revenue:
$662.00K
Net Income/Loss:
$-29.02M
P/E Ratio:
-0.0882
EPS:
-8.5
Net Cash Flow:
$-12.54M
1W Performance:
-36.98%
1M Performance:
-36.98%
6M Performance:
-76.19%
1Y Performance:
-86.10%
Orgenesis Inc Stock (ORGS) Company Profile
Compare ORGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ORGS
Orgenesis Inc
|
0.7499 | 0 | 662.00K | -29.02M | -12.54M | -8.50 |
|
ARGX
Argen X Se Adr
|
929.61 | 55.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.02 | 110.91B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
197.40 | 41.21B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
376.63 | 40.48B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.31 | 72.89B | 14.25B | 4.58B | 3.88B | 41.77 |
Orgenesis Inc Stock (ORGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-18 | Initiated | Dawson James | Buy |
Orgenesis Inc Stock (ORGS) Latest News
Is Orgenesis Inc. (45O) stock suitable for passive index fundsMarket Weekly Review & Reliable Volume Spike Trade Alerts - newser.com
Will Orgenesis Inc. (45O) stock split increase liquidityJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
Why institutional investors increase stakes in Orgenesis Inc. (45O) stockTrade Signal Summary & High Win Rate Trade Tips - newser.com
Is Orgenesis Inc. (45O) stock included in top ETFsQuarterly Trade Review & High Win Rate Trade Tips - newser.com
How Orgenesis Inc. (45O) stock compares with top peersWatch List & Trade Opportunity Analysis - newser.com
Will Orgenesis Inc. (45O) stock beat international competitionWeekly Market Report & Low Volatility Stock Recommendations - newser.com
Genital Warts Treatment Market Set to Explode from 2025 to 2032 - openPR.com
What analysts say about Orgenesis Inc 45O stockMarket Capitalization Trends & Breakout Stock Alerts - earlytimes.in
Is Orgenesis Inc 45O a good long term investmentTechnical Resistance Breaks & Stay One Step Ahead of Risk Events - earlytimes.in
Why Orgenesis Inc. (45O) stock gets analyst attentionQuarterly Market Summary & AI Driven Price Predictions - fcp.pa.gov.br
Why Orgenesis Inc. (45O) stock remains top ratedWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Orgenesis Inc Stock (ORGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):